User:David Canner/Sandbox 6: Difference between revisions

David Canner (talk | contribs)
No edit summary
David Canner (talk | contribs)
No edit summary
Line 24: Line 24:
**[[Pore forming toxin, α-hemolsyin|α-hemolsyin]]
**[[Pore forming toxin, α-hemolsyin|α-hemolsyin]]
**[[Amino Acids]] with info about [[Selenocysteine]] and [[Pyrrolysine]]
**[[Amino Acids]] with info about [[Selenocysteine]] and [[Pyrrolysine]]
**[[ACE|Angiotensin Converting Enzyme]]
**[[Annexin]]
**[[Annexin]]
**[[Antizyme Inhibitor]]
**[[Antizyme Inhibitor]]
Line 40: Line 41:


*D - L
*D - L
**[[David Canner's Favorites]]
**[[DHFR]]
**[[DHFR]]
**[[Dihydrofolate reductase]]
**[[Dihydrofolate reductase]]
Line 78: Line 80:
**[[User:Eric Martz/Molecular Playground/HIVDrug|HIV Drug]]
**[[User:Eric Martz/Molecular Playground/HIVDrug|HIV Drug]]
**[[Herpes Simplex Virus Thymidine Kinase]]
**[[Herpes Simplex Virus Thymidine Kinase]]
**[[HMGR|HMG-CoA Reductase]]
**[[IgA]]
**[[IgA]]
**[[Influenza hemagglutinin]]
**[[Influenza hemagglutinin]]
Line 106: Line 109:
**[[OhrR]]
**[[OhrR]]
**[[P53]]
**[[P53]]
**[[PPAR|Peroxisome Proliferator-Activated Receptor]]
**[[PcrA helicase]]
**[[PcrA helicase]]
**[[Personal favorites]]
**[[Personal favorites]]
Line 149: Line 153:
**[[Treatment of Gaucher disease]]
**[[Treatment of Gaucher disease]]
**[[Tropomyosin]]
**[[Tropomyosin]]
**[[VEGF|Vascular Endothelial Growth Factor]]
**[[VEGFR|Vascular Endothelial Growth Factor Receptor]]
**[[Villin]]
**[[Villin]]
**[[Vinculin]]
**[[Vinculin]]